Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy

Journal of Surgical Oncology

Volumn 62, Issue 1, 1996, Pages 40-45

  Culine, Stéphane ^a,c   Lhomme, Catherine ^a   Michel, Guy ^a   Leclere, Jérome ^a   Duvillard, Pierre ^a   Droz, Jean Pierre ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CENTRE LÉON BÉRARD   (France)

^c CENTRE VAL D AURELLE   (France)

Author keywords

germ cell tumors; ovary; second look; surgery

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; TUMOR MARKER; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LAPAROTOMY; OVARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; SECOND LOOK SURGERY; TERATOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GERMINOMA; HUMANS; LAPAROTOMY; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; REMISSION INDUCTION; REOPERATION; RETROSPECTIVE STUDIES; TERATOMA;

EID: 0029981233     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199605)62:1<40::AID-JSO9>3.0.CO;2-R     Document Type: Article

References (25)

1. Williams SD: Current management of ovarian germ cell tumors. Oncology 8:53-60, 1994.
2. Adcock LL: Germ cell tumors of the ovary-lymph node metastases. Gynecol Oncol 23:234-240, 1986.
3. Pipitt CH, Cain JM, Hakes TB, et al.: Primary chemotherapy and the role of second-look laparotomy in nondysgerminomatous germ cell malignancies of the ovary. Gynecol Oncol 31:268-275, 1988.
4. Curtin JP, Rubin SC, Hoskins WJ, et al.: Second-look laparotomy in endodermal sinus tumor: A report of two patients with normal levels of alpha-fetoprotein and residual tumor at reexploration. Obstet Gynecol 73:893-895, 1989.
5. Creasman WT, Soper JT: Assessment of the contemporary management of germ cell malignancies of the ovary. Am J Obstet Gynecol 153:828-834, 1985.
6. Gershenson DM, Copeland LJ, Del Junco G: Second-look laparotomy in the management of malignant germ cell tumors of the ovary. Obstet Gynecol 67:789-794, 1986.
7. Williams SD, Blessing JA, Disaia PJ, et al.: Second-look laparotomy in ovarian germ cell tumors: the Gynecologic Oncology Group experience. Gynecol Oncol 52:287-291, 1994.
8. Culine S, Lhomme C, Kattan J, et al.: Long-term results of two VAB-like regimens (vinbiastine + dactinomycin + bleomycin + cyclophosphamide + cisplatin) in malignant germ cell tumours of the ovary. Eur J Cancer 30A: 1239-1244, 1994.
9. Gershenson DM, Morris M, Cangir A, et al.: Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol 8:715-720, 1990.
10. Culine S, Kattan J, Lhomme C, et al.: A phase II study of high-dose cisplatin, vinbiastine, bleomycin and etoposide (PVeBV regimen) in malignant non-dysgerminomatous germ-cell tumors of the ovary. Gynecol Oncol 54:47-53, 1994.
11. Kurman RJ, Norris HJ: Malignant mixed germ-cell tumors of the ovary. Obstet Gynecol 48:579-589, 1976.
12. Gallion H, Van Nagell JR, Powell DF, et al.: Therapy of endodermal sinus tumor of the ovary. Am J Obstet Gynecol 135:447-451, 1979.
13. Gershenson DM, Del Junco G, Herson J, Rutledge FN: Endodermal sinus tumor of the ovary: The M.D. Anderson experience. Obstet Gynecol 61:194-202, 1983.
14. Slayton RE, Park RC, Silverberg SG, et al.: Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell rumors of the ovary: A Gynecologic Oncology Group study (A final report). Cancer 56:243-248, 1985.
15. Williams SD, Blessing JA, Moore DH, et al.: Cisplatin, vinblastine and bleomycin combination chemotherapy in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group. Ann Intern Med 14:22-27, 1989
16. Williams SD, Blessing JA, Liao SY, et al.: Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: A trial of the Gynecologic Oncology Group. J Clin Oncol 12:701-706, 1994.
17. Afridi MA, Vongtama V, Tsukada Y, Piver MS: Dysgerminoma of the ovary: Radiation therapy for recurrence and metastases. Am J Obstet Gynecol 126:180-194, 1976.
18. Bjorkholm E, Lundell M, Gyftodimos A, Silversward C: Dysgerminoma: The Radiumhemmet series 1927-1984. Cancer 65:38-44, 1990.
19. Mitchell MF, Gershenson DM, Soeters RP, et al.: The long-term effects of radiotherapy on patients with ovarian dysgerminoma. Cancer 67:1084-1090, 1991
20. Gershenson DM, Wharton T, Kline RC, et al.: Chemotherapeutic complete remission in patients with metastatic ovarian dysgerminoma: Potential for cure and preservation of reproduction capacity. Cancer 58:2594-2599, 1986.
21. Williams SD, Blessing JA, Hatch KD, Homesley HD: Chemotherapy of advanced dysgerminoma: Trials of the Gynecologic Oncology Group. J Clin Oncol 9:1950-1955, 1991.
22. Einhorn LH: Testicular cancer: A new and improved model. J Clin Oncol 9:1777-1781, 1990.
23. Loehrer PJ, Hui S, Clark S, et al.: Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: A clinicopathological correlation. J Urol 135:1183-1189, 1986.
24. Kattan J, Droz JP, Culine S, et al.: The growing teratoma syndrome: A woman with nonsemmomatous germ cell tumor of the ovary. Gynecol Oncol 49:395-399, 1993.
25. Jumean HG, Komorowski R, Mahvi D, Anderson T: Immature teratoma of the ovary. An unusual case. Gynecol Oncol 46:111-114, 1992.